The latest news in cancer research, health and policy by Cancer Research UK.
We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy.
Acute Lymphoblastic Leukaemia All
A new treatment increases survival to almost 70 per cent for children whose acute lymphoblastic leukaemia (ALL) returns.
Cancer Research UK's Drug Development Office has opened the first trial of a new type of leukaemia drug.
A study has revealed that variations in genes can affect the likelihood of children with leukaemia to having side-effects from chemotherapy.
An international team of scientists has discovered a potential new treatment target for T-cell acute lymphoblastic leukaemia (T-ALL).
Treatment with genetically modified immune cells caused remission in patients with a particular type of acute leukaemia, according to a small US trial.